Impact Factor Collection


Endocrine Connections impact factor graphic

Endocrine Connections' 2019 Impact Factor has risen to 2.592.

This Impact Factor highlights the high-quality, engaging and unique research that the Editorial Board has helped become published to a global audience.

To celebrate Endocrine Connections' new Impact Factor, the journal Editorial Team have compiled a collection of highly cited articles contributing to the latest Impact Factor.


Highly cited in 2019


Interobserver agreement of various thyroid imaging reporting and data systems
Giorgio Grani et al.

On type 1 diabetes mellitus pathogenesis
Stavroula A Paschou et al.

Thyroid-disrupting chemicals and brain development: an update
Bilal B Mughal, Jean-Baptiste Fini and Barbara A Demeneix

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
C E Higham et al.

The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders
Werner F Blum et al.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults
Gudmundur Johannsson et al.

Cancer treatment in childhood and testicular function: the importance of the somatic environment
Jan-Bernd Stukenborg et al.

Hypokalemia: a clinical update
Efstratios Kardalas et al.

Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa
K Amrein et al.

Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study
Henrik Falhammar et al.

Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer
Tiemo S Gerber et al.

Bisphenol A, phthalate metabolites and glucose homeostasis in healthy normal-weight children
Amalie Carlsson et al.

IGF-1 protects SH-SY5Y cells against MPP+-induced apoptosis via PI3K/PDK-1/Akt pathway
Chanyang Kim and Seungjoon Park

Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
E T Aristizabal Prada et al.

Circulating vitamin D level and mortality in prostate cancer patients: a dose–response meta-analysis
Zhen-yu Song et al.

Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis
Qiu-ming Yao et al.

Depression in type 1 diabetes was associated with high levels of circulating galectin-3
Eva Olga Melin et al.

Vitamin D, PCOS and androgens in men: a systematic review
Christian Trummer et al.

Immunotherapy failure in adrenocortical cancer: where next?
Deborah Cosentini et al.

Vitamin D supplementation does not improve CVD risk factors in vitamin D-insufficient subjects
Julia Kubiak et al.